Know Cancer

or
forgot password

Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child


Phase 3
N/A
15 Years
Open (Enrolling)
Both
Children Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)

Thank you

Trial Information

Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child


Inclusion Criteria:



- Children weighing 30 kg or less with a diagnosis of haematological malignancy or
solid tumour, who were candidates for HSCT were eligible for inclusion in the study.

- Written informed consent was required from parents of eligible children.

Exclusion Criteria:

- Children were excluded if they had a anti-HLA and/or anti-HPA antibody, if they were
prior included in this study or if the parents declined to participate.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

The primary end point of the study was tocompare the number of platelet concentrates donors who were implicated in platelet transfusion supportive after HSCT.

Principal Investigator

Valérie LAPIERRE, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Gustave Roussy, Cancer Campus, Grand Paris

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

Minnie

NCT ID:

NCT00180986

Start Date:

October 1995

Completion Date:

Related Keywords:

  • Children Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)

Name

Location